
Our Unique Tech Features
VerAvanti’s Scanning Fiber Endoscope (SFE) redefines intravascular imaging with forward-looking, high-resolution technology. Unlike side-view methods, it will offer real-time, full-color visuals deep within arteries, revealing plaques and defects with unmatched clarity. Featuring a 1 mm probe and over 1.2 million pixels, the SFE platform will deliver laser-based, high-resolution imaging while eliminating blind spots for precise lesion assessment.

Potential Future Applications
VerAvanti's innovative imaging technology aims to extend its capabilities far beyond intravascular health, addressing critical needs across multiple medical fields. From gastroenterology and pulmonology to urology and dental care, our advanced solutions could empower clinicians with unparalleled diagnostic precision and therapeutic guidance.
02
By The Numbers*
50+
Our technology is backed by over 50 patents, protecting and advancing exclusive imaging and endoscopic capabilities.
Patents For Advancing Imaging and Endoscopic Capabilities
10x
Our single-use design is crafted with the goal of reducing cross-contamination risks by up to 10 times the current rate, supporting safer procedures for patients.
We Aim To Reduce Cross-Contamination Risks
30%
Our technology is developed to help streamline complex procedures, with the potential to reduce operating time and improve patient throughput.
Possible Reduction In Procedure Time With Improved Efficiency
1
Our endoscope is designed to contribute to cost efficiency, with the possibility of just one additional procedure offering measurable ROI.
Procedure Aims To Cover The Entire Unit Investment
99.99%
Our device aims to achieve illumination efficiency far beyond standard CMOS cameras, working to provide clear and precise imaging for diagnostics.
Illumination Efficiency Potential vs. Traditonal CMOS Solutions
40%
Our advanced imaging technology aspires to support higher success rates with the goal of improving patient outcomes.
Aiming For Higher Success Rates In Complex Cases
* Source: JACC: Cardiovascular Interventions. "Chronic Total Occlusion Percutaneous Coronary Interventions: Evidence, Techniques, and Outcomes." Accessed at https://www.jacc.org/doi/full/10.1016/j.jcin.2009.02.008.
See The VerAvanti SFE Advantage


